Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT – Get Free Report) was the recipient of a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 21,391 shares, a drop of 32.6% from the December 31st total of 31,742 shares. Based on an average trading volume of 20,233 shares, the short-interest ratio is presently 1.1 days. Currently, 0.0% of the company’s shares are short sold. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 20,233 shares, the short-interest ratio is presently 1.1 days.
Zhengye Biotechnology Trading Up 4.0%
Shares of ZYBT opened at $0.98 on Friday. The company’s fifty day simple moving average is $1.55 and its 200-day simple moving average is $3.95. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.49 and a quick ratio of 1.10. Zhengye Biotechnology has a twelve month low of $0.90 and a twelve month high of $14.30.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Zhengye Biotechnology in a research note on Friday, January 9th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.
Institutional Trading of Zhengye Biotechnology
Several institutional investors have recently added to or reduced their stakes in the company. Millennium Management LLC purchased a new position in Zhengye Biotechnology in the 3rd quarter worth about $38,000. Citadel Advisors LLC bought a new position in Zhengye Biotechnology in the 3rd quarter worth about $31,000. WINTON GROUP Ltd bought a new position in Zhengye Biotechnology in the 3rd quarter worth about $56,000. Jane Street Group LLC purchased a new position in shares of Zhengye Biotechnology during the second quarter worth approximately $1,158,000. Finally, Invesco Ltd. bought a new stake in shares of Zhengye Biotechnology during the second quarter valued at approximately $220,000.
Zhengye Biotechnology Company Profile
Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.
Featured Stories
- Five stocks we like better than Zhengye Biotechnology
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Zhengye Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhengye Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
